| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10967821 | Vaccine | 2012 | 7 Pages |
Abstract
⺠In 2009, an H1N1 monovalent influenza vaccine was recommended in addition to the seasonal vaccine. ⺠We evaluated the immunogenicity and safety of H1N1 influenza vaccine in immunocompromised children. ⺠The H1N1 vaccine was safe and well tolerated in children with cancer, HIV, and sickle cell disease. ⺠The H1N1 vaccine resulted in an adequate immune response in children with sickle cell disease. ⺠The H1N1 vaccine was only modestly immunogenic in children with cancer or HIV infection.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Hana Hakim, Kim J. Allison, Lee-Ann Van De Velde, Yimei Li, Patricia M. Flynn, Jonathan A. McCullers,